PL341062A1 - Novel applications of compounds exhibiting antipsoric properties - Google Patents

Novel applications of compounds exhibiting antipsoric properties

Info

Publication number
PL341062A1
PL341062A1 PL98341062A PL34106298A PL341062A1 PL 341062 A1 PL341062 A1 PL 341062A1 PL 98341062 A PL98341062 A PL 98341062A PL 34106298 A PL34106298 A PL 34106298A PL 341062 A1 PL341062 A1 PL 341062A1
Authority
PL
Poland
Prior art keywords
antipsoric
properties
compounds exhibiting
novel applications
novel
Prior art date
Application number
PL98341062A
Inventor
Don E Griswold
Siegfried Benjamin Christensen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PL341062A1 publication Critical patent/PL341062A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL98341062A 1997-10-17 1998-10-16 Novel applications of compounds exhibiting antipsoric properties PL341062A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6374697P 1997-10-17 1997-10-17
PCT/US1998/021886 WO1999020280A1 (en) 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity

Publications (1)

Publication Number Publication Date
PL341062A1 true PL341062A1 (en) 2001-03-26

Family

ID=22051225

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98341062A PL341062A1 (en) 1997-10-17 1998-10-16 Novel applications of compounds exhibiting antipsoric properties

Country Status (18)

Country Link
EP (1) EP1030666A4 (en)
JP (1) JP2001520196A (en)
KR (1) KR20010031149A (en)
CN (1) CN1306426A (en)
AR (1) AR015966A1 (en)
AU (1) AU740875B2 (en)
BR (1) BR9814080A (en)
CA (1) CA2306985A1 (en)
CO (1) CO4810374A1 (en)
CZ (1) CZ20001376A3 (en)
HU (1) HUP0003792A3 (en)
IL (1) IL135581A0 (en)
NO (1) NO20001847D0 (en)
NZ (1) NZ503551A (en)
PL (1) PL341062A1 (en)
TR (1) TR200001040T2 (en)
WO (1) WO1999020280A1 (en)
ZA (1) ZA989450B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
CA2436535A1 (en) 2001-01-31 2002-08-08 Prizer Products Inc. Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
EE200300362A (en) 2001-01-31 2003-12-15 Pfizer Products Inc. Thiazolyl, oxazolyl, pyrrolyl and imidazolylic acid amide derivatives used as inhibitors of PDE4 isozymes
HUP0302891A2 (en) 2001-01-31 2003-12-29 Pfizer Products Inc. Ether derivatives useful as inhibitors of pde4 isozymes, their use and pharmaceutical compositions containing them
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
EP1647274A4 (en) * 2003-07-17 2008-12-10 Ono Pharmaceutical Co Remedy for pruritus comprising piperidine derivative as the active ingredient
JP2005187458A (en) * 2003-12-04 2005-07-14 Santen Pharmaceut Co Ltd Itchiness-treating agent consisting of cilomilast or its salt as active ingredient
WO2005053672A1 (en) * 2003-12-04 2005-06-16 Santen Pharmaceutical Co., Ltd. Remedy for pruritus comprising cilomilast or salt thereof as the active ingredient
WO2005077950A2 (en) 2004-02-14 2005-08-25 Smithkline Beecham Corporation Medicaments with hm74a receptor activity
JP2008137892A (en) * 2005-03-04 2008-06-19 Eisai Co Ltd Antipruritic agent
BRPI0614270A2 (en) 2005-08-10 2011-03-22 Smithkline Beecham Corp xanthine derivatives as selective ha74a agonists
TWI404709B (en) * 2006-02-21 2013-08-11 Eisai R&D Man Co Ltd 4-(3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
EP1992622B1 (en) * 2006-02-21 2011-07-27 Eisai R&D Management Co., Ltd. 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
EP2123641A4 (en) 2007-02-16 2011-06-22 Eisai R&D Man Co Ltd Crystal, amorphous form and salt of methyl n-ý3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl¨terephthalamic acid
CN102336717B (en) 2007-08-17 2013-09-18 卫材R&D管理有限公司 Quinazoline derivative
US8513269B2 (en) 2007-08-17 2013-08-20 Eisai R&D Management Co., Ltd. Preparation for external use
US20140121240A1 (en) 2011-06-28 2014-05-01 Maruho Co., Ltd. Novel pharmaceutical composition
EA034139B1 (en) 2015-01-30 2020-01-09 Шаньтонь Фарма Ко., Лтд. Prevention or treatment of uric acid or gout diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563168B1 (en) * 1990-12-21 2000-07-05 Beecham Group Plc Xanthine derivatives
ATE224386T1 (en) * 1996-03-26 2002-10-15 Altana Pharma Ag NEW 6-POSITION SUBSTITUTED PHENANTHRIDINE
ES2187775T3 (en) * 1996-05-15 2003-06-16 Altana Pharma Ag IMIDAZOPIRIDINS.
DE69817548T2 (en) * 1997-03-07 2004-06-17 Altana Pharma Ag TETRAZOLE DERIVATIVES
PL336464A1 (en) * 1997-03-18 2000-06-19 Basf Ag Method of and compositions for modulating reactivity in respect to corticosteroids i
WO1998055481A1 (en) * 1997-06-03 1998-12-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine

Also Published As

Publication number Publication date
IL135581A0 (en) 2001-05-20
ZA989450B (en) 1999-04-19
AU740875B2 (en) 2001-11-15
TR200001040T2 (en) 2001-01-22
CA2306985A1 (en) 1999-04-29
KR20010031149A (en) 2001-04-16
AU1093899A (en) 1999-05-10
WO1999020280A1 (en) 1999-04-29
CZ20001376A3 (en) 2002-06-12
NZ503551A (en) 2002-05-31
CN1306426A (en) 2001-08-01
HUP0003792A3 (en) 2001-12-28
EP1030666A4 (en) 2002-10-16
BR9814080A (en) 2000-09-26
HUP0003792A2 (en) 2001-10-28
CO4810374A1 (en) 1999-06-30
NO20001847L (en) 2000-04-10
NO20001847D0 (en) 2000-04-10
AR015966A1 (en) 2001-05-30
EP1030666A1 (en) 2000-08-30
JP2001520196A (en) 2001-10-30

Similar Documents

Publication Publication Date Title
PL341672A1 (en) Derivatives of benzothiazepin exhibiting hypolipidemic properties
ZA9810217B (en) New composition of matter
PL341062A1 (en) Novel applications of compounds exhibiting antipsoric properties
GB2330182B (en) Manufacture of gaskets
PL331470A1 (en) Azabicyclocarbamoyloxylic derivatives of mutiline for antibacterial applications
GB9404703D0 (en) Production of difluoromethane
AU3057299A (en) Sustained-release composition containing cefaclor
PL321546A1 (en) Novel applications of lysozime dimers
PL342733A1 (en) Biocement of improved properties
ZA985760B (en) Glass composition of the silica-soda-lime-type
GB9722451D0 (en) The manufacture of gaskets
PL328669A1 (en) Novel applications of pyrrole derivatives
ZA9810718B (en) Novel crystal modification of thiazine-indigo
IL130670A0 (en) Manufacture of elongate members
PL325816A1 (en) Novel derivatives of naphtylpiperazine
GB9318277D0 (en) Production of difluoromethane
GB9706377D0 (en) Novel compound
PL319263A1 (en) Novel derivative of pyrimidinylcarbazole
GB9722026D0 (en) Use of compounds
GB9306089D0 (en) Production of difluoromethane
GB9306072D0 (en) Production of difluoromethane
GB9324777D0 (en) Production of difluoromethane
GB9306079D0 (en) Production of difluoromethane
AUPO627197A0 (en) Applications of LED's
GB9810260D0 (en) Novel use of quinine